iRhythm Technologies Dirección
Dirección controles de criterios 2/4
El CEO de iRhythm Technologies es Quentin Blackford , nombrado en Oct 2021, tiene una permanencia de 3.08 años. compensación anual total es $16.60M, compuesta por 4.1% salario y 95.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.26% de las acciones de la empresa, por valor de $6.59M. La antigüedad media del equipo directivo y de la junta directiva es de 2.5 años y 7.3 años, respectivamente.
Información clave
Quentin Blackford
Chief Executive Officer (CEO)
US$16.6m
Compensación total
Porcentaje del salario del CEO | 4.1% |
Permanencia del CEO | 3.1yrs |
Participación del CEO | 0.3% |
Permanencia media de la dirección | 2.5yrs |
Promedio de permanencia en la Junta Directiva | 7.3yrs |
Actualizaciones recientes de la dirección
Recent updates
iRhythm Technologies: Today's 510(K) Victory May Only Be A Temporary Reprieve
Oct 22Take Care Before Jumping Onto iRhythm Technologies, Inc. (NASDAQ:IRTC) Even Though It's 26% Cheaper
Oct 13Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?
Sep 19Getting In Cheap On iRhythm Technologies, Inc. (NASDAQ:IRTC) Might Be Difficult
Jul 13iRhythm Technologies (NASDAQ:IRTC) Is Carrying A Fair Bit Of Debt
May 13iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't
Mar 25Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results
Feb 25iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?
Feb 02iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate
Dec 20iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable
Dec 20Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?
Dec 02Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?
Sep 20iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate
Aug 30When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?
Jul 04Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?
Jun 16Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)
May 26iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark
May 08What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?
Mar 27Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?
Feb 25Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?
Nov 24iRhythm falls after reaffirming 2022 guidance
Sep 21iRhythm: Fairly Priced At Current Multiples, No Need To Size Up
Sep 02Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?
Aug 18iRhythm Technologies Q2 results beat estimates, co raises FY 2022 revenue guidance
Aug 04Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$151m |
Jun 30 2024 | n/a | n/a | -US$132m |
Mar 31 2024 | n/a | n/a | -US$130m |
Dec 31 2023 | US$17m | US$677k | -US$123m |
Sep 30 2023 | n/a | n/a | -US$105m |
Jun 30 2023 | n/a | n/a | -US$99m |
Mar 31 2023 | n/a | n/a | -US$105m |
Dec 31 2022 | US$8m | US$650k | -US$116m |
Sep 30 2022 | n/a | n/a | -US$128m |
Jun 30 2022 | n/a | n/a | -US$131m |
Mar 31 2022 | n/a | n/a | -US$124m |
Dec 31 2021 | US$10m | US$163k | -US$101m |
Compensación vs. Mercado: La compensación total de Quentin($USD16.60M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD6.60M).
Compensación vs. Ingresos: La compensación de Quentin ha aumentado mientras la empresa no es rentable.
CEO
Quentin Blackford (45 yo)
3.1yrs
Permanencia
US$16,595,149
Compensación
Mr. Quentin S. Blackford serves as an Independent Director of Paragon 28, Inc. since August 1, 2022. He serves as President and Chief Executive Officer since October 04, 2021 and serves as Director at iRhy...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
President | 3.1yrs | US$16.60m | 0.26% $ 6.6m | |
Chief Medical & Scientific Officer and Executive VP of Product Innovation | 2.6yrs | US$5.32m | 0.015% $ 390.0k | |
Chief Business & Legal Officer | 2.9yrs | US$5.33m | 0.031% $ 768.5k | |
Chief Commercial Officer | 2.3yrs | US$5.77m | 0.025% $ 632.5k | |
Executive Vice President of Business Operations | 1.3yrs | sin datos | 0.0023% $ 58.9k | |
Senior VP of Finance & Chief Accounting Officer | 1.3yrs | sin datos | 0.0029% $ 73.0k | |
Executive VP of Corporate Development & Investor Relations | 5.4yrs | US$3.54m | 0.098% $ 2.5m | |
Executive VP & Chief Risk Officer | 2.5yrs | sin datos | 0.074% $ 1.9m | |
Director of Investor Relations | no data | sin datos | sin datos |
2.5yrs
Permanencia media
45yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de IRTC se considera experimentado (2.5 años antigüedad media).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
President | 2.8yrs | US$16.60m | 0.26% $ 6.6m | |
Independent Director | 7.3yrs | US$233.12k | 0.032% $ 811.8k | |
Medical Director & Member of Scientific Advisory Board | no data | sin datos | sin datos | |
Independent Director | 7.3yrs | US$240.25k | 0.030% $ 759.4k | |
Independent Chairman | 8.5yrs | US$286.74k | 0.055% $ 1.4m | |
Medical Director & Member of Scientific Advisory Board | no data | sin datos | sin datos | |
Member of Scientific Advisory Board | no data | sin datos | sin datos | |
Independent Director | 6.6yrs | US$230.62k | 0.018% $ 464.6k | |
Independent Director | 8.7yrs | US$248.12k | 0.034% $ 851.8k | |
Medical Director & Member of Scientific Advisory Board | no data | sin datos | sin datos | |
Independent Director | 3yrs | US$239.97k | 0.020% $ 512.4k | |
Medical Director & Member of Scientific Advisory Board | no data | sin datos | sin datos |
7.3yrs
Permanencia media
67yo
Promedio de edad
Junta con experiencia: La junta directiva de IRTC se considera experimentada (7.3 años de antigüedad promedio).